Latest Capital Markets News

Global Uranium and Enrichment Limited has obtained a crucial ASX waiver allowing the cancellation of certain unlisted options without shareholder approval, smoothing the path for Snow Lake Resources’ acquisition scheme.

Greatland Resources confirms Havieron as a world-class, long-life gold-copper mine with robust economics and full funding secured. The feasibility study outlines a 17-year mine life with steady production and competitive costs leveraging existing Telfer infrastructure.

Pivotal Metals highlights its fully funded exploration programs targeting high-grade copper and gold deposits in Quebec, underpinned by a significant pit-constrained resource and strategic advantages in a tier 1 jurisdiction.

Conico Ltd has appointed a new external auditor and secured shareholder approval for a significant 1-for-8 share consolidation at its 2025 Annual General Meeting.

Activeport Group Ltd has revised the timetable for its pro-rata bonus issue of unquoted options, outlining key dates and eligible shareholders across multiple countries.

Ionic Rare Earths Limited secured shareholder approval on all resolutions at its 2025 Annual General Meeting, including director election, share consolidation, and capital raising measures.

ikeGPS Group reports a robust first half of FY26 with subscription revenue surging 47%, driven by AI innovation and strong market demand. The company reaffirms its FY26 growth targets amid a solid balance sheet and leadership expansion.

BTC Health has raised $2 million through a share placement priced at a slight premium, with director Martin Kahanovitz participating and a new South African investor joining the register.

CD Private Equity Fund III reported a $3.02 million net loss for the half-year ending September 2025, driven largely by foreign currency translation losses, yet maintained a 10 cent per unit distribution supported by portfolio realisations and cash management.

Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.

Alliance Aviation Services reported record FY25 revenue and flying hours but faces margin pressures from rising costs and a major contract renegotiation. The company’s refreshed leadership is focused on operational improvements and debt reduction in FY26.

BOA Resources has acquired a significant stake in the Neds Creek copper project in Western Australia’s Murchison region, setting the stage for a major exploration push in 2026 focused on the drill-ready Ricci Lee prospect.